aod9604 peptide before and after You're Injecting AOD-9604 WRONG! Doctor Explains How to Inject AOD-9604 (not what you think) Order AOD 9604 (3mg) |

This product is supplied for research purposes only and is not offered for human or veterinary use

Subcutaneous (SC) Injections Subcutaneous injections involve injecting B12 into the fatty tissue just beneath the skin

In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]

Lipo B12 injections bypass this step

The safety-related interpretation of 5-Amino-1MQ should not begin with assumptions drawn from peptide receptor agonists such as semaglutide as a GLP-1 receptor agonist peptide, amylin-related research agents such as cagrilintide, dietary ingredients, cosmetic ingredients, or clinically developed metabolic agents